BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8243650)

  • 1. Nature of the pH-induced conformational changes and exposure of the C-terminal region of chromogranin A.
    Yoo SH; Ferretti JA
    FEBS Lett; 1993 Nov; 334(3):373-7. PubMed ID: 8243650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization and tetramerization properties of the C-terminal region of chromogranin A: a thermodynamic analysis.
    Yoo SH; Lewis MS
    Biochemistry; 1993 Aug; 32(34):8816-22. PubMed ID: 8364029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH- and Ca(2+)-induced conformational change and aggregation of chromogranin B. Comparison with chromogranin A and implication in secretory vesicle biogenesis.
    Yoo SH
    J Biol Chem; 1995 May; 270(21):12578-83. PubMed ID: 7759505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High capacity, low affinity Ca2+ binding of chromogranin A. Relationship between the pH-induced conformational change and Ca2+ binding property.
    Yoo SH; Albanesi JP
    J Biol Chem; 1991 Apr; 266(12):7740-5. PubMed ID: 2019597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pH and Ca2+ on monomer-dimer and monomer-tetramer equilibria of chromogranin A.
    Yoo SH; Lewis MS
    J Biol Chem; 1992 Jun; 267(16):11236-41. PubMed ID: 1597459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2(+)-induced conformational change and aggregation of chromogranin A.
    Yoo SH; Albanesi JP
    J Biol Chem; 1990 Aug; 265(24):14414-21. PubMed ID: 2387861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-dependent association of chromogranin A with secretory vesicle membrane and a putative membrane binding region of chromogranin A.
    Yoo SH
    Biochemistry; 1993 Aug; 32(32):8213-9. PubMed ID: 8347621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium on recombinant bovine chromogranin A.
    Angeletti RH; Ali G; Shen N; Gee P; Nieves E
    Protein Sci; 1992 Dec; 1(12):1604-12. PubMed ID: 1304892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent binding of chromogranin B and secretory vesicle matrix proteins to the vesicle membrane.
    Yoo SH
    Biochim Biophys Acta; 1993 Nov; 1179(3):239-46. PubMed ID: 8218367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic study of the pH-dependent interaction of chromogranin A with an intraluminal loop peptide of the inositol 1,4,5-trisphosphate receptor.
    Yoo SH; Lewis MS
    Biochemistry; 1995 Jan; 34(2):632-8. PubMed ID: 7819258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion.
    Angeletti RH; Mints L; Aber C; Russell J
    Endocrinology; 1996 Jul; 137(7):2918-22. PubMed ID: 8770914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
    Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
    Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) -- evidence of dimer-monomer equilibria.
    Corti A; Sanchez LP; Gasparri A; Curnis F; Longhi R; Brandazza A; Siccardi AG; Sidoli A
    Eur J Biochem; 1997 Sep; 248(3):692-9. PubMed ID: 9342219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A: posttranslational modifications in secretory granules.
    Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
    Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the secretory vesicle membrane binding region of chromogranin B.
    Yoo SH; Kang YK
    FEBS Lett; 1997 Apr; 406(3):259-62. PubMed ID: 9136897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
    Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
    Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent interaction of an intraluminal loop of inositol 1,4,5-trisphosphate receptor with chromogranin A.
    Yoo SH; Lewis MS
    FEBS Lett; 1994 Mar; 341(1):28-32. PubMed ID: 8137917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the secretory vesicle membrane binding region of chromogranin A.
    Kang YK; Yoo SH
    FEBS Lett; 1997 Mar; 404(1):87-90. PubMed ID: 9074643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between an intraluminal loop peptide of the inositol 1,4,5-trisphosphate receptor and the near N-terminal peptide of chromogranin A.
    Yoo SH; Lewis MS
    FEBS Lett; 1998 May; 427(1):55-8. PubMed ID: 9613599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.